![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, December 07, 2020 9:48:19 PM
Remember they switched from skin cancer which is the easiest to treat with radiogel, the Mayo Clinic suggested to switching the testing on lymph node cancers. Which is more difficult to treat and I think it’s in the middle of the list for difficulty to treat. So if this gets the green light, all the cancers that are easier to treat will more than likely be grouped under the lymph nodes.
What does that mean, that means at least 10-15 more cancers radiogel can add to the list and start immediately to treat besides the lymph nodes cancer.
Also as soon as the fda gives the green light to start human testing, guess what they now are eligible to be used in the right to try on any cancers. So while testing for lymph node cancers, they could easily be testing on much worse cancers as well. The best thing is, is that they are at a cancer hospital with endless cases.
Once approved it won’t take very long to get approved for the European markets. S
So in short break through device gets approved shortens human testing from years to months. Fda will probably fairly quickly approve for human testing if they approve the break through device designation. So realistically they could be human testing by spring. By October possible approval for market. Don’t forget about isopet, by summer next year they could have this procedures cost reduced dramatically to where it’s more affordable hopefully.
Is $600 a share possible, if all of this happens. Yes it is very possible. They have around 30 cancers listed that they believe they can use radiogel on. Each one is easily multiple billions of dollars a year for treatment.
Recent RDGL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM